Communications Biology (May 2024)

Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury

  • Yi Wang,
  • Xiaolong Fu,
  • Li Zeng,
  • Yan Hu,
  • Rongyang Gao,
  • Siting Xian,
  • Songjie Liao,
  • Jianxiang Huang,
  • Yonggang Yang,
  • Jilong Liu,
  • Hai Jin,
  • James Klaunig,
  • Yuanfu Lu,
  • Shaoyu Zhou

DOI
https://doi.org/10.1038/s42003-024-06243-0
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Nuclear factor erythroid 2-related factor-2 (Nrf2) antioxidant signaling is involved in liver protection, but this generalization overlooks conflicting studies indicating that Nrf2 effects are not necessarily hepatoprotective. The role of Nrf2/heme oxygenase-1 (HO-1) in cholestatic liver injury (CLI) remains poorly defined. Here, we report that Nrf2/HO-1 activation exacerbates liver injury rather than exerting a protective effect in CLI. Inhibiting HO-1 or ameliorating bilirubin transport alleviates liver injury in CLI models. Nrf2 knockout confers hepatoprotection in CLI mice, whereas in non-CLI mice, Nrf2 knockout aggravates liver damage. In the CLI setting, oxidative stress activates Nrf2/HO-1, leads to bilirubin accumulation, and impairs mitochondrial function. High levels of bilirubin reciprocally upregulate the activation of Nrf2 and HO-1, while antioxidant and mitochondrial-targeted SOD2 overexpression attenuate bilirubin toxicity. The expression of Nrf2 and HO-1 is elevated in serum of patients with CLI. These results reveal an unrecognized function of Nrf2 signaling in exacerbating liver injury in cholestatic disease.